• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Anthera Pharmaceuticals Inc

+ Add to Watchlist

ANTH:US

1.5800 USD 0.1000 6.76%

As of 20:10:00 ET on 12/26/2014.

Snapshot for Anthera Pharmaceuticals Inc (ANTH)

Open: 1.4700 Day's Range: 1.4700 - 1.5900 Volume: 277,284
Previous Close: 1.4800 52wk Range: 1.4600 - 3.7900 1-Yr Rtn: -43.37%

Stock Chart for ANTH

No chart data available.
  • ANTH:US 1.5800
  • 1D
  • 1M
  • 1Y
1.4800
Interactive ANTH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ANTH

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.5200
Est. EPS (USD) (12/2014) -1.3000
Est. PEG Ratio -
Market Cap (M USD) 36.24
Shares Outstanding (M) 22.94
30 Day Average Volume 169,106
Price/Book (mrq) 8.1164
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ANTH

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ANTH

Anthera Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing anti-inflammatory therapeutics for cardiovascular diseases, lupus and other serious diseases.

Paul F TruexPresident/CEO/FounderDebra OdinkSenior VP/CTO
Colin HislopSenior VP/Chief Medical OfcrMay LiuSenior VP:Finance & Administration
More Company Profile & Key Executives for ANTH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil